47426-201 : Cinvanti 130 mg/18ml Intravenous Injection, Emulsion


NDC47426-201
Labeler: Heron Therapeutics
Product Type: Human Prescription Drug
Drug Name:  Cinvanti
Dosage Form: Intravenous Injection, Emulsion
Application #: NDA209296
Rev. Date: 


NDC Package Codes:

  • 47426-201-01: 1 VIAL, GLASS IN 1 CARTON (47426‑201‑01) > 18 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Aprepitant

Dosage Strength:

  • 130 mg/18mL

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 47426-201 QR Code

< Prev: 47426-101Next: 47444-001 >

Related Discussions:

Pantoprazole 40mg and Aprepitant 80
I am taking Pantoprazole for severe acid reflux. Yesterday I started chemotherapy for breast cancer and have been prescr... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 January 2018.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA